National Securities Starts Oramed Pharma (ORMP) at Buy, $23 PT
Tweet Send to a Friend
National Securities initiates coverage on Oramed Pharma (NASDAQ: ORMP) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


